Role of asprosin and meteorin-like peptide in progression of actinic keratosis to squamous cell carcinoma

References

• Alemán MR, Santolaria F, Batista N, Maria J, González-Reimers E, Milena A, Llanos M, Gómez-Sirvent JL. 2002. Leptin role in advanced lung cancer. A mediator of the acute phase response or a marker of the status of nutrition? Cytokine. 19:21–26. doi: 10.1006/cyto.2002.1051.
   PubMed Web of Science ®Google Scholar
• Al Jabaari B, Ladyman H, Larche M, Sivolapenko G, Epenetos A, Ritter M. 1989. Elevated expression of the interleukin 4 receptor in carcinoma: a target for immunotherapy? Br J Cancer. 59:910–914. doi: 10.1038/bjc.1989.192.
   PubMed Web of Science ®Google Scholar
• Arany Z, Foo S-Y, Ma Y, Ruas JL, Bommi-Reddy A, Girnun G, Cooper M, Laznik D, Chinsomboon J, Rangwala SM, Baek KH, Rosenzweig A, Spiegelman BM. 2008. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1α. Nature. 451:1008–1012. doi: 10.1038/nature06613.
   PubMed Web of Science ®Google Scholar
• Aydin S, Kuloglu T, Ozercan M, Albayrak S, Aydin S, Bakal U, Yilmaz M, Kalayci M, Yardim M, Sarac M, Kazez A. 2016. Irisin immunohistochemistry in gastrointestinal system cancers. Biotech Histochem. 91:242–250. doi: 10.3109/10520295.2015.1136988.
   PubMed Web of Science ®Google Scholar
• Barb D, Neuwirth A, Mantzoros CS, Balk SP. 2007. Adiponectin signals in prostate cancer cells through akt to activate the mammalian target of rapamycin pathway. Endocr Rel Cancer. 14:995–1005. doi: 10.1677/ERC-06-0091.
   PubMed Web of Science ®Google Scholar
• Berhane T, Halliday G, Cooke B, Barnetson RSC. 2002. Inflammation is associated with progression of actinic keratoses to squamous cell carcinomas in humans. Br J Dermatol. 146:810–815. doi: 10.1046/j.1365-2133.2002.04720.x.
   PubMed Web of Science ®Google Scholar
• Carter JH, Douglass LE, Deddens JA, Colligan BM, Bhatt TR, Pemberton JO, Konicek S, Hom J, Marshall M, Graff JR. 2004. Pak-1 expression increases with progression of colorectal carcinomas to metastasis. Clin Cancer Res. 10:3448–3456. doi: 10.1158/1078-0432.CCR-03-0210.
   PubMed Web of Science ®Google Scholar
• Clair DKS, Oberley TD, Muse KE, Clair WHS. 1994. Expression of manganese superoxide dismutase promotes cellular differentiation. Free Rad Biol Med. 16:275–282. doi: 10.1016/0891-5849(94)90153-8.
   PubMed Web of Science ®Google Scholar
• Drane P, Bravard A, Bouvard V, May E. 2001. Reciprocal down-regulation of p53 and SOD2 gene expression–implication in p53 mediated apoptosis. Oncogene. 20:430–439. doi: 10.1038/sj.onc.1204101.
   PubMed Web of Science ®Google Scholar
• Farag AG, Elnaidany NF, El-Dien MMS. 2016. Immunohistochemical expression of leptin in nonmelanoma skin cancer. J Clin Diagn Res. 10:WC08–WC12. doi: 10.7860/JCDR/2016/19755.8385.
   PubMedGoogle Scholar
• Fernandez Figueras M. 2017. From actinic keratosis to squamous cell carcinoma: pathophysiology revisited. J Eur Acad Dermatol Venereol. 31:5–7. doi: 10.1111/jdv.14151.
   PubMed Web of Science ®Google Scholar
• Fryknäs M, Rickardson L, Wickström M, Dhar S, Lövborg H, Gullbo J, Nygren P, Gustafsson MG, Isaksson A, Larsson R. 2006. Phenotype-based screening of mechanistically annotated compounds in combination with gene expression and pathway analysis identifies candidate drug targets in a human squamous carcinoma cell model. J Biomol Screen. 11:457–468. doi: 10.1177/1087057106288048.
   PubMed Web of Science ®Google Scholar
• Goldberg LH, Chang JR, Baer SC, Schmidt JD. 2000. Proliferative actinic keratosis: three representative cases. Dermatol Surg. 26:65–69. doi: 10.1046/j.1524-4725.2000.99157.x.
   PubMed Web of Science ®Google Scholar
• Goto Y, Arigami T, Kitago M, Nguyen SL, Narita N, Ferrone S, Morton DL, Irie RF, Hoon DS. 2008. Activation of Toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors. Mol Cancer Ther. 7:3642–3653. doi: 10.1158/1535-7163.MCT-08-0582.
   PubMed Web of Science ®Google Scholar
• Karia PS, Han J, Schmults CD. 2013. Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. J Am Acad Dermatol. 68:957–966. doi: 10.1016/j.jaad.2012.11.037.
   PubMed Web of Science ®Google Scholar
• Kocaman N, Artaş G. 2020. Can novel adipokines, asprosin and meteorin-like, be biomarkers for malignant mesothelioma? Biotech Histochem. 95:171–175. doi: 10.1080/10520295.2019.1656344.
   PubMed Web of Science ®Google Scholar
• Kovács D, Fazekas F, Oláh A, Törőcsik D. 2020. Adipokines in the skin and in dermatological diseases. Int J Mol Sci. 21: 9048:1–29. doi: 10.3390/ijms21239048.
   Web of Science ®Google Scholar
• Lalji A, Lalji M. 2014. Actinic keratosis and squamous cell carcinoma. Clin Res Dermatol Open. 1:1–3. doi: 10.15226/2378-1726/1/1/00102.
   Google Scholar
• LeBleu VS, O’Connell JT, Herrera KNG, Wikman H, Pantel K, Haigis MC, De Carvalho FM, Damascena A, Chinen LTD, Rocha RM, Asara JM, Kalluri R. 2014. PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat Cell Biol. 16:992–1003. doi: 10.1038/ncb3039.
   PubMed Web of Science ®Google Scholar
• Lee JO, Lee HJ, Lee YW, Han JA, Kang MJ, Moon J, Shin M-J, Lee HJ, Chung JH, Lee J-S. 2018. Meteorin-like (METRNL) adipomyokine improves glucose tolerance in type 2 diabetes via AMPK pathway. BioRxiv. 420489:1–37. doi: 10.1101/420489.
   Google Scholar
• Lee C-H, Wu S-B, Hong C-H, Liao W-T, Wu C-Y, Chen G-S, Wei Y-H, Yu H-S. 2011. Aberrant cell proliferation by enhanced mitochondrial biogenesis via mtTFA in arsenical skin cancers. Am J Pathol. 178:2066–2076. doi: 10.1016/j.ajpath.2011.01.056.
   PubMed Web of Science ®Google Scholar
• Lee T, Yun S, Jeong JH, Jung TW. 2019. Asprosin impairs insulin secretion in response to glucose and viability through TLR4/JNK-mediated inflammation. Mol Cell Endocrinol. 486:96–104. doi: 10.1016/j.mce.2019.03.001.
   PubMed Web of Science ®Google Scholar
• Li Z-Y, Song J, Zheng S-L, Fan M-B, Guan Y-F, Qu Y, Xu J, Wang P, Miao C-Y. 2015. Adipocyte metrnl antagonizes insulin resistance through PPARγ signaling. Diabetes. 64:4011–4022. doi: 10.2337/db15-0274.
   PubMed Web of Science ®Google Scholar
• Manning AA, Zhao L, Zhu Z, Xiao H, Redington CG, Ding VA, Stewart-Hester T, Bai Q, Dunlap J, Wakefield MR, Fang Y. 2019. IL-39 acts as a friend to pancreatic cancer. Med Oncol. 36:1–7. doi: 10.1007/s12032-018-1236-y.
   Web of Science ®Google Scholar
• Marks R, Foley P, Goodman G, HAGE BH, Selwood T. 1986. Spontaneous remission of solar keratoses: the case for conservative management. Br J Dermatol. 115:649–655. doi: 10.1111/j.1365-2133.1986.tb06644.x.
   PubMed Web of Science ®Google Scholar
• Neely EK, Morhenn VB, Hintz RL, Wilson DM, Rosenfeld RG. 1991. Insulin-like growth factors are mitogenic for human keratinocytes and a squamous cell carcinoma. J Invest Dermatol. 96:104–110. doi: 10.1111/1523-1747.ep12515914.
   PubMed Web of Science ®Google Scholar
• Oblak A, Jerala R. 2011. Toll-like receptor 4 activation in cancer progression and therapy. Clin Dev Immunol. 2011:1–12. doi: 10.1155/2011/609579.
   Google Scholar
• Rao RR, Long JZ, White JP, Svensson KJ, Lou J, Lokurkar I, Jedrychowski MP, Ruas JL, Wrann CD, Lo JC, Camera D, Lachey J, Gygi S, Seehra J, Hawley J, Spiegelman B. 2014. Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell. 157:1279–1291. doi: 10.1016/j.cell.2014.03.065.
   PubMed Web of Science ®Google Scholar
• Romere C, Duerrschmid C, Bournat J, Constable P, Jain M, Xia F, Saha PK, Del Solar M, Zhu B, York B, Sarkar P, Rendon D, Gaber M, LeMaire S, Coselli J, Milewicz D, Sutton V, Butte N, Moore D, Chopra A. 2016. Asprosin, a fasting-induced glucogenic protein hormone. Cell. 165:566–579. doi: 10.1016/j.cell.2016.02.063.
   PubMed Web of Science ®Google Scholar
• Sander C, Hamm F, Elsner P, Thiele J. 2003. Oxidative stress in malignant melanoma and non‐melanoma skin cancer. Br J Dermatol. 148:913–922. doi: 10.1046/j.1365-2133.2003.05303.x.
   PubMed Web of Science ®Google Scholar
• Stratigos A, Garbe C, Lebbe C, Malvehy J, Del Marmol V, Pehamberger H, Peris K, Becker JC, Zalaudek I, Saiag P, Middleton MR, Bastholt L, Testori A, Grob J-J. 2015. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. Eur J Cancer. 51:1989–2007. doi: 10.1016/j.ejca.2015.06.110.
   PubMed Web of Science ®Google Scholar
• Tennakoon JB, Shi Y, Han JJ, Tsouko E, White MA, Burns AR, Zhang A, Xia X, Ilkayeva OR, Xin L, Ittmann MM, Rick FG, Schally AV, Frigo DE. 2014. Androgens regulate prostate cancer cell growth via an AMPK-PGC-1α-mediated metabolic switch. Oncogene. 33:5251–5261. doi: 10.1038/onc.2013.463.
   PubMed Web of Science ®Google Scholar
• Ushach I, Burkhardt AM, Martinez C, Hevezi PA, Gerber PA, Buhren BA, Schrumpf H, Valle-Rios R, Vazquez MI, Homey B, Zlotnik A. 2015. Meteorin-like is a cytokine associated with barrier tissues and alternatively activated macrophages. Clin Immunol. 156:119–127. doi: 10.1016/j.clim.2014.11.006.
   PubMed Web of Science ®Google Scholar
• Werner R, Sammain A, Erdmann R, Hartmann V, Stockfleth E, Nast A. 2013. The natural history of actinic keratosis: a systematic review. Br J Dermatol. 169:502–518. doi: 10.1111/bjd.12420.
   PubMed Web of Science ®Google Scholar
• Xu X, Zhang C, Xia Y, Yu J. 2020. Overexpression of METRN predicts poor clinical prognosis in colorectal cancer. Mol Genet Genom Med. 8:e1102. doi: 10.1002/mgg3.1102.
   PubMed Web of Science ®Google Scholar
• Yuan M, Li W, Zhu Y, Yu B, Wu J. 2020. Asprosin: a novel player in metabolic diseases. Front Endocrinol. 11:1–7. doi: 10.3389/fendo.2020.00064.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Tan Y, Zhu L, Zhang B, Feng P, Gao E, Xu C, Wang X, Yi W, Sun Y. 2019. Asprosin improves the survival of mesenchymal stromal cells in myocardial infarction by inhibiting apoptosis via the activated ERK1/2-SOD2 pathway. Life Sci. 231:1–12. doi: 10.1016/j.lfs.2019.03.010.
   Web of Science ®Google Scholar